Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 207209
Company: MACLEODS PHARMS LTD

Products on ANDA 207209

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
REPAGLINIDE	REPAGLINIDE	0.5MG	TABLET;ORAL	Prescription	AB	No	No
REPAGLINIDE	REPAGLINIDE	1MG	TABLET;ORAL	Prescription	AB	No	No
REPAGLINIDE	REPAGLINIDE	2MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 207209

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
03/22/2023	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 207209

REPAGLINIDE

TABLET;ORAL; 0.5MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
REPAGLINIDE	REPAGLINIDE	0.5MG	TABLET;ORAL	Prescription	No	AB	203820	AUROBINDO PHARMA LTD
REPAGLINIDE	REPAGLINIDE	0.5MG	TABLET;ORAL	Prescription	No	AB	078555	CHARTWELL RX
REPAGLINIDE	REPAGLINIDE	0.5MG	TABLET;ORAL	Prescription	No	AB	207209	MACLEODS PHARMS LTD

TABLET;ORAL; 1MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
REPAGLINIDE	REPAGLINIDE	1MG	TABLET;ORAL	Prescription	No	AB	203820	AUROBINDO PHARMA LTD
REPAGLINIDE	REPAGLINIDE	1MG	TABLET;ORAL	Prescription	No	AB	078555	CHARTWELL RX
REPAGLINIDE	REPAGLINIDE	1MG	TABLET;ORAL	Prescription	No	AB	207209	MACLEODS PHARMS LTD

TABLET;ORAL; 2MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
REPAGLINIDE	REPAGLINIDE	2MG	TABLET;ORAL	Prescription	No	AB	203820	AUROBINDO PHARMA LTD
REPAGLINIDE	REPAGLINIDE	2MG	TABLET;ORAL	Prescription	No	AB	078555	CHARTWELL RX
REPAGLINIDE	REPAGLINIDE	2MG	TABLET;ORAL	Prescription	No	AB	207209	MACLEODS PHARMS LTD